Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Relay Therapeutics, Inc. (RLAY) had Free Cash Flow per Share of $-0.43 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$7.68M |
|
$-77.06M |
|
-- |
|
$7.68M |
|
$92.55M |
|
$-84.87M |
|
$7.80M |
|
$-77.06M |
|
$-77.06M |
|
$-77.06M |
|
$-77.06M |
|
$-77.06M |
|
$-77.06M |
|
$-84.87M |
|
$-85.26M |
|
169.23M |
|
169.23M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$739.66M |
|
$5.15M |
|
$59.70M |
|
$799.36M |
|
$37.05M |
|
-- |
|
$41.23M |
|
$78.28M |
|
$721.08M |
|
$718.78M |
|
$721.08M |
|
170.44M |
|
| Cash Flow Statement Financials | |
$-73.21M |
|
$42.47M |
|
$0.00M |
|
$126.41M |
|
$95.66M |
|
$-30.75M |
|
$19.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1105.21% |
|
-1105.21% |
|
-- |
|
-1003.58% |
|
-1003.58% |
|
$-73.59M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-10.69% |
|
-10.72% |
|
-9.64% |
|
-10.69% |
|
$4.23 |
|
|
Free Cash Flow per Share |
$-0.43 |
$-0.43 |
|